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care delivery. In randomly selected villages a sales agent was locally recruited and in-
centivized to conduct home visits, educate households on essential health behaviors,
provide medical advice and referrals, and sell preventive and curative health prod-
ucts. Results after three years show substantial health impact: under-5 child mortality
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1. Introduction
Despite significant reductions in child and infant mortality over the last few decades,
about one in twelve children in sub-Saharan Africa still die before his or her fifth birthday
(UN, 2015). Many, if not most, of these deaths can be avoided through simple preventa-
tive care and through simple, low cost treatments delivered at home. This means that
an effective response to reduce child deaths is not out of reach. While health outcomes
can be tied to a host of factors, both on the demand and supply side, there is limited ev-
idence on effective and scalable solutions to the problem (Dupas and Miguel, 2016). In
this paper, we focus on the role of delivery on basic health services and products to poor
communities at the very end of the supply chain. How to combat child mortality in this
space is arguably of first order importance from a policy-making perspective. On the one
hand, evidence shows that when household get access to very basic health products and
services, free of charge, mortality is substantially reduced (Kumar et al, 2008; Baqui et al,
2008). On the other hand, even if such solutions are socially desirable in the long run, in
the short run they imply severe feasibility challenges in countries with poor state capacity
in general, and service delivery capacity in particular.
In this paper, more specifically, we study the impact of a novel “social entrepreneur-
ship” approach – the Living Goods model – to community health delivery.1 The model cre-
ates “Avon-like” networks of door-to-door mobile Community Health Promoters (CHP).
The main activities of the CHPs resemble the standard activities of any community health
worker: conduct home visits within their community, educate households on essential
health behaviors, provide basic medical advice, and refer the more severe cases to the
closest health center. On top of this, the CHPs make a modest income by selling a di-
verse basket of basic health goods, ranging from anti-malaria drugs to soap and fortified
foods. CHPs purchase these products directly from the NGOs at wholesale price and earn
1The definition of social entrepreneurship is admittedly somewhat elusive, but typically entails a parallel
approach of pecuniary (for-profit) and social goals. For a discussion, see Martin and Osberg (2007).
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a margin on each product sold. Product prices are set by the NGOs in two dimensions:
the price the CHPs are allowed to procure products at and their retail price. Products are
effectively cross-subsidized to provide larger incentives on products that are believed to
facilitate the greatest child mortality reductions, given existing market conditions. The
underlying hypothesis is that these incentives on products, coupled with small finan-
cial incentives to encourage timely services2, would not only move households down the
demand curve but also motivate community health promoters to actively provide basic
health services to mothers, newborn, and children. Thus, the CHPs operated as micro-
entrepreneurs with financial incentives to meet household demand and improve child
health.
The program was randomized across 214 rural villages spread across Uganda and was
fully operational in all treatment clusters, with at least one CHP locally recruited to the
program, by the beginning of 2011.3 Our results show after three years, the intervention
resulted in a substantial health impact: under-5 child mortality was reduced approxi-
mately by 27%, infant (i.e. under 1 year) mortality by 33% and neonatal (i.e. under 1
month) mortality by 28%.
While the evidence shows that households in treatment villages were more signifi-
cantly likely to use products sold by the CHPs, such as insecticide treated bed nets and
oral re-hydration salts for treating diarrhea – consistent with the effects on mortality –,
we also provide suggestive evidence that the effects were not simply driven by access to
cheaper, high quality, medicines and health products. In particular, the largest increases
in the treatment relative the control group in terms of behavior were observed for follow-
up visits and counseling. Households with a newborn baby were more than 70% more
likely to have received a follow-up visit in the first week after birth, and households with
2The CHPs received small performance-based incentives to encourage registering of pregnant women
and visits of newborns ($0.65 per registration/newborn visit).
3The rollout of the CHP program, including the trial clusters, was overseen by an advisory board includ-
ing individuals with expertise in international public health and health service research as well as officials
from the Uganda Ministry of Health.
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a child under-five that fell sick with malaria or diarrhea were, respectively, 73% and 62%
more likely to have received a follow-up visit. For households with infants that fell sick
with malaria or diarrhea the increases were 109% and 105%, respectively. These results
suggest that the efficacy of the program was not only a result of the pecuniary incentives
to sell products, at least not directly, but also the provision of life-saving services. These
findings add to the small but growing literature that investigates the role financial in-
centives can play in motivating individuals engaged in pro-social activities (Ashraf et al,
2014; Olken et al, 2014; Luo et al, 2015).
To facilitate policy making, we also assess the effectiveness of the program and per-
form a cost-benefit analysis taking into account fixed and variable costs. Our results in-
dicate that the average cost per averted death was $4,237. This figure is about 40% of the
cost per life saved that the Guttmacher Institute estimated could be achieved by expand-
ing a range of health services known to be effective at saving lives (Perry and Zulliger,
2012). Taking into account that life expectancy in this context is vastly improved condi-
tional on surviving the first few years of life, the estimated cost per life-year gained is
equal to $71. This figure compares favorably to existing estimates, ranging from $82 per
life-year gained in Kenya to $3,396 per life-year gained in Indonesia (Borghi et al, 2005;
McPake et al, 2015).
The remainder of the paper is organized as follows. Details on the study setting, the
research design, and the intervention are presented in section 2. Section 3 reports the
main results. In section 4 we perform a robustness analysis. Section 5 presents the cost-
effectiveness estimates and section 6 concludes.
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2. Intervention and Empirical Design
2.1. The Program
In 2007 Living Goods, a US based NGO active in Uganda, in collaboration with BRAC
Uganda began piloting a new community health delivery model intended to improve
maternal, newborn and child health. Unlike volunteer-based community health worker
programs, the community health promoter (CHP) program harnesses the power of fran-
chised direct selling to provide CHPs with incentives to increase poor households’ ac-
cess to low-cost, high-impact health products and basic newborn and child health ser-
vices. The CHP program was organized into geographically based branches, managed
by branch managers and supervised by two NGOs (Living Goods and BRAC Uganda).
Each CHP was assigned to a specific cluster, which in most cases corresponds to one vil-
lage.
The CHP program is ongoing and by the end of the evaluation period in 2013 it
was operating in 883 clusters (villages), organized in 29 branches, located in 23 districts,
spread over all four regions of Uganda (see figure 14). Thereafter the program continued
to expand and by end of 2016 reached more than 5,500 clusters, organized in 143 branches,
with a total population of over 4.4 million.
[FIGURE 1 ABOUT HERE]
The CHPs were selected through a competitive process among female community
members aged 18 to 45 who applied for the position in each village and who possessed
basic writing and math skills. Eligible candidates received 2 weeks of health and busi-
ness training, covering preventing, diagnosing and treating childhood illness, recogniz-
ing danger signs for referral, healthy pregnancy and newborn care, and nutrition. At the
4Figure A.1 in Appendix provides a set of more detailed images by study district.
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end of the training, a skills test was administered to determine who would become an
active CHP. Selected CHPs also attended a one-day training each month to review and
refresh key health and business topics.
The CHPs tasks were to conduct home visits to households with children under five
years old, educate households on essential health behaviors, provide basic medical ad-
vice, referring the more severe cases to the closest health center, and to diagnose illness
and sell preventive and curative health products. The CHPs were also instructed to visit
newborns within the first 48 hours of life and to encourage pregnant women to deliver in
a facility or with professional assistance.5
The product line the CHPs had at disposal included prevention goods (e.g. insecticide
treated bednets, water purification tablets, and vitamins), curative treatments (e.g. oral
re-hydration salts, zinc, and ACTs), as well as other health-related commodities (e.g. di-
apers, detergent, and hand soap) and durables with health benefits (e.g. improved cook
stoves, solar lights, and water filters). As mentioned in the introduction, the broad prod-
uct mix and the pricing strategy had three potential benefits: (i) driving up total sales and
income for the CHPs; (ii) enabling the NGOs to cross-subsidize prices across products;
(iii) motivating agents to be out visiting households regularly, thanks to the presence
of high-velocity items in the product mix6. The products were sold by the CHP gener-
ally below prevailing market prices. The retail price was indeed determined by country
management with a target of keeping prices for preventive and curative products on av-
erage 10% lower than the prevailing local market prices. The CHPs, in turn, purchased
these products directly from Living Goods or BRAC branches at wholesale prices on av-
erage 30% below market prices and therefore earned an income on each product sold.
Although the exact pricing strategy kept changing with the market conditions, CHPs
5Similar health services are in the public health literature often labeled as iCCM (integrated community
case management) and MNCH (maternal, newborn, and child health) services.
6The business training received by the CHPs explicitly stressed the importance of building up a
customer-base by providing free services like health education, referrals, and newborn visits. In addition,
the CHPs received small performance-based incentives to encourage registering of pregnant women and
visits of newborns ($0.65 per registration/newborn visit).
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typically maintained higher margins on goods aimed to improve child health and reduce
child mortality. Overall, the CHPs operated as micro-entrepreneurs with financial incen-
tives to meet household demand and improve child health. The two NGOs also managed
to keep their own margins at 10% at least, by buying the products largely directly from
the producers, national importers, or national distributors.
2.2. Comparison with traditional community health workers and re-
lated literature
In many developing countries, as is the case in Uganda, the primary strategy to ex-
tend primary health care from facilities to under-served rural communities is community
health workers (CHWs) (Singh and Sachs, 2013). In contrast with the Living Goods model,
traditional CHW programs lack explicit monetary incentives (Bhutta et al, 2010; Christo-
pher et al, 2011; Gilmore and McAuliffe, 2013; Haines et al, 2007; Perry and Zulliger,
2012). Specifically, community health work is often voluntary, but workers face compet-
ing opportunities such as paid-work or home production, that may lead them to devote
less time to caregiving. Unsurprisingly, most of the evidence on the positive impact of
CHW programs come from studies in settings with high quality supervision and sup-
port. Such a monitoring system may not be achievable in routine field situations. How to
incorporate incentives to motivate CHWs in large-scale CHW programs, and the impact
that will have, are open questions.
Systematic reviews of existing studies show that CHWs can be impactful in promot-
ing positive health behavior and in providing basic curative and health services (Bhutta
et al, 2010; Christopher et al, 2011; Gilmore and McAuliffe, 2013; Gogiaa and Sachdeva,
2010; Haines et al, 2007; Lewin et al, 2010; Naimoli et al, 2012; Okwundu et al, 2013; Perry
and Zulliger, 2012). However, the findings from reviews of randomized controlled trials
of CHW programs and CHW-led interventions are mixed (Lewin et al, 2010; Okwundu
et al, 2013). Two proof-of-principle studies cited as evidence in the WHO and UNICEF
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home-visits strategy statement documented large reductions in neonatal mortality (36-
54%) (Kumar et al, 2008; Baqui et al, 2008). Four trials delivered in a program setting
documented smaller (8-15%) – and in three out of four trials not statistically significant
– impact (Darmstadt et al, 2010; Bhutta et al, 2011; Bhandari et al, 2012; Kirkwood et
al, 2013). Two studies assessed the impact of community-based training of mothers, of
which one focused on teaching mothers curative treatments of malaria, finding a 40% re-
duction in under-5 mortality (Kidane and Morrow, 2000), and one focused on teaching
child care to expectant and postpartum women, finding instead no significant impact on
neonatal and infant mortality (Sloan et al, 2008). Finally, two trials assessed the impact
of Integrated Management of Childhood Illness program in Bangladesh (Arifeen et al,
2009) and Ethiopia (Amouzou et al, 2016), finding no significant effect on under-5 mor-
tality. Our study adds to this literature by evaluating for the first time whether a social
entrepreneurial approach to health care delivery can lead to significant improvements in
children’s health.
Our study also contributes to the literature on the effect of incentives for agents en-
gaged in pro-social activities. Most literature in this area has focused on the education
sector and on the impact of performance incentives for teachers (e.g. Lavy 2002; Glewwe
et al, 2010; Muralidharan and Sundararaman, 2011; Duflo et al, 2012). Recently, however,
four studies have looked into the impact of incentives on the delivery of health services.
Within the context of rural China, Miller et al (2012) relied on a randomized trial to study
the role of incentives for school principals to reduce anaemia among their students, find-
ing a modest effect.7 In Indonesia, Olken et al (2014) studied a program that links aid
disbursements for health and education to the performance of health services, finding
significant short-run improvements in health indicators. In Zambia, Ashraf et al (2014)
7In a new randomized controlled trial, performed in a similar setting, the authors find that large (but
not small) incentives as well as larger unconditional grants succeed in reducing anemia substantially, with
incentives being the most cost-effective solution. The authors also find that performance incentives and
unrestricted grants work as substitutes, with the larger unconditional grants completely crowding-out the
positive effect of incentives (Luo et al, 2015).
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evaluated the effect of both financial and non-financial incentives on the performance
of agents recruited by a public health organization, finding, among other things, that
both types of rewards are effective when their relative value is high and that the effect
is stronger for pro-socially motivated agents. Finally, within the context of government
child care health workers in India, Singh (2015) showed that combining performance pay
with information provision to mothers leads to a significant reduction in malnutrition,
although individually the effects are negligible.
2.3. Study design and participants
The study was a parallel-group, stratified cluster randomized controlled trial, embedded
in the roll-out of the CHP program. 214 clusters (rural villages) took part in the trial.
The clusters were located in 12 geographical zones spread across Uganda (see figure 1).
Within each zone, the clusters were randomly divided into a treatment group and a con-
trol group. In 11 zones out of 12 the randomization was balanced (1:1). In one zone
and for operational purposes the randomization was unbalanced (2:1). At least one CHP
was assigned to each cluster in the treatment group.8 No CHP was assigned to the control
clusters. All clusters were enumerated at baseline. There were on average 237 households
per cluster at baseline.
The main objective of the trial was to assess the impact of having a CHP working in
the cluster on improving children’s health. The evaluation design and implementation
was independent of program implementation.
The outcomes of interest were measured through a cross-sectional household survey
administered between September and December 2013; approximately three years after
the CHPs began operating in the treatment clusters. Before implementing the survey, each
cluster was enumerated. A random computer-generated sequence was then used to se-
8One CHP was assigned to each cluster, with the exception of few large clusters, where two or three
CHPs were assigned.
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lect 40 households to be surveyed in each cluster (if less than 40 eligible households were
available, all were sampled). The analysis was based on a final sample of 7,018 house-
holds, and their 11,563 under-5 children, that have lived in the same cluster throughout
the trial. The final sample was slightly smaller than the cross-sectional household survey
since households that migrated out from the baseline cluster were not included in the
final analysis, nor were households that migrated into the trial clusters during the study
period.
Sampled households were visited and asked for written informed consent to partici-
pate in the survey. Conditional on receiving the consent, an appointment was scheduled
for the following day. The respondent was the female household head if available at the
time of the interview or the primary female health care giver of the household. If neither
could be found, or the household refused to participate, a replacement household was
chosen (this happened in 7.2% of the cases, without any systematic difference between
treatment and control clusters). Random back-checks were performed to ensure that all
enumerators correctly followed the protocol.
The survey was implemented by Innovations for Poverty Action (IPA) Uganda and
the survey teams were all composed by local staff with previous experience in data collec-
tion. Different survey teams operated in the different districts covered by the evaluation,
to ensure that every staff member was familiar with local customs and spoke the local
language. Data collectors were always masked to whether they were interviewing in an
treatment or control cluster.
The trial was embedded in the rollout of the full CHP program (883 clusters) and
there were no differences in program implementation between the treatment clusters (115
clusters) and the 768 clusters that were not part of the trial.
The CHPs were blinded to the trial status of the village they were assigned to avoid
that the evaluation itself affected the CHPs behavior. As a consequence, no surveillance
and monitoring system was put in place in the trial clusters and we did not track a pre-
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determined set of households to avoid the CHP focusing their efforts on the households
that were tracked at the expense of those who were not. Mortality rates were calculated
based on cross-sectional household survey data collected at the end of the trial, using
data from households that had resided in the same cluster throughout the trial. To ensure
that these households were not systematically different in the two assignment groups,
we tested for differential in- and out-migration during the trial period and checked for
balance across assignment groups using pre-trial determined observable household char-
acteristics, and pre-trial infant mortality rates, collected at the end of the trial period.
All households and especially households with children under-five were potential re-
cipients of visits from the CHPs. While the CHPs were recommended to focus attention
on providing services to households living within their cluster, they were not prevented
from selling or providing advice also to households outside the cluster, including control
clusters. Similarly, households living outside the treatment clusters could visit a CHP in
an treatment cluster.
Households in both treatment and control clusters could benefit from primary health
care services provided by other actors, including private clinics, public primary health
dispensaries and village health teams (a government community health worker program).
2.4. Randomization
Figure 2 describes the trial profile. As the full CHP program was rolled out over time, the
randomization of clusters was also phased in over time. We began in 2009 with a sample
of 200 clusters (villages) in 10 geographic zones (8 districts). The clusters were stratified
by zone and size (below or above 400 households) and, within each stratum, half of the
clusters were assigned to the treatment group and half were assigned to the control group
through a simple randomization procedure (computerized random numbers) generated
by the researchers. In 2010, a year before the evaluation began; a decision was taken to
only include clusters with less than 400 households at baseline as the design of the trial
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was deemed less suitable for clusters where the CHPs only would be able to serve a small
minority of the households. As a consequence, 10 strata with 94 clusters (47 treatment
and 47 control) were deemed ineligible. 60 clusters organized in one new geographic
zone were added in the end of 2010. Half of these 60 clusters were randomly assigned
to the treatment group and half were assigned to the control group, following the same
procedure adopted for the other zones. An additional zone was added in the beginning
of 2011. For operational purposes, 1/3 of the 48 clusters in the final zone were randomly
assigned to the control group and the remaining 2/3 of the clusters were allocated to
the treatment group. The final sample for the trial thus consisted of 214 clusters (115
treatment and 99 control) in 12 zones (10 districts). Concerning the division between
the two NGOs, 106 clusters (53 treatment and 53 control) were in BRAC-managed areas,
while 108 were in LG-managed areas (62 treatment and 46 control). The program was
fully operational in all treatment clusters in the beginning of 2011. Endline survey was
conducted after three years, at the end of 2013.
[FIGURE 2 HERE]
2.5. Outcomes
The pre-specified primary outcome was under-five mortality rate (U5MR). Secondary
outcomes were infant mortality rate (IMR) and neonatal mortality rate (NMR). All mor-
tality rates were calculated using the sample household survey data collected at the end
of the trial. The household survey recorded detailed birth and death information for all
children under five living in the households at the time of the survey as well as for all
children that died under the age of five in the previous three years. For each child, we
defined the number of month of exposure to the risk of death during the trial period,
defined as the difference between the birth date of the child, or the start date of the trial
(January 2011) if the child was born before that date, and the date that the child turned
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five years if that occurred during the trial period, or the date of the endline household
survey if the child was less than five years old at that time, or the date of the death of the
child (see Figure A.2). Under-five mortality was then calculated as number of under-five
deaths over the trial period per 1000 child-years of exposure to the risk of dying under the
age of five. Infant mortality was calculated as number of deaths during the trial period
arising within the first year of life per 1000 infant-years of exposure, with infant-years of
exposure calculated in a similar way as the child-years of exposure to the risk of death.
Neonatal mortality was calculated as number of deaths during the trial period within the
first month of life per 1000 births.9
Additional secondary outcomes of interest were CHP interactions (to measure pro-
gram coverage); follow-up visits; health knowledge and prevention; under-five morbid-
ity (in self-reported malaria and diarrhea); treatment of under-five children for malaria
and diarrhea; antenatal, delivery, and postnatal care.10 Data on all secondary outcomes
were collected in the endline sample household survey.
2.6. Sample size
The sample size was designed to detect a reduction in overall under-five mortality. In
a community-based trial in 2009 with significant overlap in the regions covered to the
CHP study, U5MR was 18 deaths per 1000 child-years with a coefficient of variation of
the incidence rates of 0.32 (Björkman et al, 2017). On the basis of these data, and 120
child-years of observations in each cluster (i.e. three years and 40 child observations per
9International organizations such as UN and WHO typically express mortality in terms of deaths per
1000 live-births. Such organizations use data collected over long periods of time and rely on a life-table ap-
proach to compute mortality as a probability. Given that our evaluation lasted only for three years, the most
appropriate approach in our case is to compute mortality as a ratio, following the steps described above,
and to express it in terms of years of exposure. For completeness and in other to facilitate comparisons
with other estimates, in the results section we will in any case also report results obtained using a life-table
approach, although they should be considered less reliable.
10Pneumonia was initially included as a secondary outcome but due to changes in the regulatory envi-
ronment, there was a delay in the authorization to include antibiotics among the list of health products
provided by the CHPs and we could therefore not study pneumonia-related outcomes in the end.
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year), a sample size of 214 clusters, of which 115 clusters are allocated to the treatment
group and 99 clusters to the control group, would detect a 27% reduction in under-five
mortality with 80% power at the two-sided 5% significance level.
3. Results
3.1. Balance at baseline
Table 1 reports balance tests using cluster-specific statistics before the program started.
Results show that clusters were not statistically different between the treatment group
and the control group in terms of size, household characteristics, and distance to main
roads, electricity transmission lines, and health facilities.
[TABLE 1 HERE]
Household data was not collected at baseline by the research team.11 We therefore use
endline data to compute infant mortality for the two years preceding the intervention; i.e.,
in 2009 and 2010. Results in Table 2 show that there was no significant difference in infant
mortality rates between the treatment and control prior to the intervention. IMR was 52.4
per 1000 child-years in the treatment group compared to 50.0 per 1000 child-years in the
control group and the p-value on the difference was 0.83.
Panel B of Table 2 shows that pre-trial determined observable household character-
istics, such as household size at the start of the trial and age and years of education of
the household head, were not statistically different between the treatment group and the
control group for the households used in the analysis; i.e., household that had remained
in the same cluster throughout the trial and surveyed in 2013.
11Baseline data was collected for most BRAC clusters by BRAC itself. Although the analysis suggests a
balanced sample, we do not include it in our discussion, due to its incomplete coverage and to the fact that
data were collected by one of the implementing agencies.
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[TABLE 2 HERE]
3.2. Health outcomes
The primary outcome measure for the trial was child mortality. Child mortality links
to the wide spectrum of child health specific services and health goods that the CHP
provides to households with children under-5. Many of these services and goods, includ-
ing health education, child preventative care, child curative care, and the medical drugs
related to deworming, malaria, and diarrhea that were sold to affordable prices to the
households, also have the potential to affect other health outcomes. We therefore also
collected measures of height, weight and hemoglobin levels of all children under-5 living
in the surveyed households.
We start by showing the findings on child mortality in table 3. The first three columns
report the results using raw data: i.e. the number of under-five, infant (under 12 months),
and neonatal (under 1-month) deaths per year. In order to assess the impact of the pro-
gram, here as well as in the remaining of the paper, we compare mean outcomes after
accounting for stratification. That is, we estimate
(1) Yij = βTij + bj + eij ,
where Yij is the outcome of interest (e.g number of under-5 deaths over the study period)
in village i, located in the geographical area associated to the NGO branch j. T is an
indicator variable for villages assigned to the treatment groups, bj are branch fixed effects,
and e is an error term.
The first three columns of the table show that the CHP program reduced the number of
deaths in all three age categories. The number of under-5 deaths dropped by 28% (column
i); the number of infant deaths dropped by 33% (column ii); the number neonatal deaths
dropped by 27% (column iii). The raw data clearly shows that the CHP program had a
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large impact on reducing mortality for young children in the treatment areas. However,
the crude death numbers may not necessarily be due purely to a reduction in the risk of
child death since cohort sizes may have been differentially affected by the intervention
due to for example differences in fertility rates. Therefore, in column (iv)-(vi) of Table 3
we are estimating the mortality rate over the period of exposure; i.e. between January
2011 to December 2013. We follow the conventional approach used in epidemiology and
define the under-five [infant] mortality rate as the number of under-five [infant] children
that died during the period per 1000 child-years [infant-years] of exposure over the same
time period. Conventionally, we define neonatal mortality as the number of neonatal
deaths per 1000 live births.
The estimated rate ratio in column (iv); i.e. the incidence of child deaths in the treat-
ment relative to the control group, implies that the risk of under-five deaths was reduced
by 27% relative to the control group. The effect is of the same order of magnitude, and
even more precisely estimated, using a linear model – a reduction of 5.95 deaths per 1000
child-years from a control group mean of 19.4 deaths per 1000. The reduction in infant
mortality (column (v)) is even larger – a 33% reduction in the risk of infant deaths in
the treatment versus the control group – and even more precisely estimated. Finally, the
number of children dying before reaching one month (per 1,000 live births) is 24.1 in the
treatment group compared to 33.4 in the control group and the difference – a reduction of
27.8% in neonatal mortality – is significant at the 5 percent level.
In columns (vii) and (viii) we also report under-5 and infant mortality expressed in
terms of deaths per 1000 live births. In this case we estimate the probabilities of deaths
by using a life-table approach. This is the methodology typically followed by interna-
tional organizations such as UN and WHO, but it is more appropriate for data spanning
longer time periods than the three years we are considering here. It however provides fig-
ures that are more easily comparable with those published by such organizations. WHO
reports under-5 and infant mortality rates for Uganda in 2013 equal to 66.1 and 43.8, re-
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spectively (UNICEF et al, 2014). Our estimates for control clusters are just slightly higher
and equal to 68.4 and 49.7 deaths per 1000 live births, respectively. Columns (vii) and
(viii) show that the intervention led to a reduction in treatment village of 19.9 deaths in
mortality under-5 (28.9% reduction) and 17.2 deaths in infant mortality (34.7% reduction).
In both cases the estimate is significant at 1%. These results appear very much in line with
what we found above.
The main outcome of the CHP program was to reduce child mortality at all levels and
the results presented in Table 3 clearly shows that the program indeed was successful in
saving children’s lives for all ages under five.
[TABLE 3 HERE]
Table 4 reports the results on weight, height, and hemoglobin levels of children un-
der 5 years old. We measured weight using portable weighing scales and height using
stadiometers. Hemoglobin levels were measured through a hemocue machine, which
is a photometer that tests hemoglobin concentration using a single drop of blood taken
from the child’s finger.12 The first four columns of table 4 report impact on height-for-age
and weight-for-height, which are the standard measures used to identify stunting and
wasting, respectively. In particular, according to WHO standards, a child is defined as
moderately stunted (wasted) if the height-for-age (weight-for-height) value is below -2
standard deviations from the reference mean.13 Results in columns (i) and (ii) suggest
that the program led to an improvement in the height-for-age measure among children
under-5, although the effects are not precisely estimated: the share of stunted children ac-
cording to WHO standards in the treatment villages decreased by 1.9 percentage points,
12The samples were collected by selected staff members that followed a specific health training. The
machine simply works by inserting a special glass (microcuvette) that contains the drop of blood just taken
from the child’s finger. The blood is analysed by the machine and the result is displayed in less than a
minute. The microvuette containing the drop of blood was safely disposed immediately after the hemocule
has revealed the hemoglobin level.
13Values are often expressed in terms of z-scores. The z-score records the anthropometric value as a
number of standard deviations below or above the reference mean or median value.
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which represents a 6.8 percent drop with respect to the prevalence in the control group,
and the effect is significant at 10%. Results in columns (iii) and (iv) show that the program
had no detectable effect on wasting. Finally, columns (v) and (vi) highlight a large and
significant improvements in hemoglobin levels, with the share of anemic children (i.e.
with hemoglobin level below 10g/dl) in the treatment group decreasing by 2.7 percent-
age points, or by 16% compared to average prevalence in the control group.
[TABLE 4 HERE]
3.3. Processes
The community health promoter program was intended to improve child health by pro-
viding basic curative and preventative health services. As we explained above, the CHPs
tasks were to conduct home visits, educate households on essential health behaviors, pro-
vide basic medical advice, refer the more severe cases to the closes health center, visit
newborn and to encourage pregnant women to seek antenatal care, as well as to sell pre-
ventative and curative health products. We have shown that the program had impact
on the ultimate outcome – child mortality – and we now turn to assessing evidence on
intermediate outcomes that relates to better child health.
Interaction and knowledge
We start by assessing the extent of interaction that households had with the community
health promoters and whether the households in the treatment areas had improved health
knowledge as part of the CHP’s education purpose.
Column (i) of able 5 shows that almost 24% of the households in the treatment clusters
have been visited by a CHP in the 30 days preceding the survey. While there was evidence
of spillovers – 5.4% of the households in the control group have also been visited by a CHP
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– households in the treatment group were more than 4 times as likely to have benefited
from such a visit.
The CHP was supposed to educate households on basic health behaviors aimed to
improve children’s health. Column (i)-(vii) in Table 5 show that households in the treat-
ment areas were indeed more informed about causes and treatments of diarrhea as well
as about causes for malaria: compared to the control area, they were 11 percent more
likely to know that diarrhea is transmitted by drinking untreated water; 16 percent more
likely to know that zinc is effective in treating diarrhea; and 38 percent more likely to
know that mosquito bites are the only cause of malaria. They were also 4.7 percentage
points (control mean is 59.1%) more likely to have heard of food with added vitamins or
nutrients. Knowledge about bednets and the importance of professional assistance when
giving birth did not differ between control and treatment groups, although in these cases
there was limited room for improvement, as even in control villages more than 99% of
respondents displayed such knowledge.
In the last column of table 5 we report average standardized effects of the health
knowledge outcomes; i.e. we estimate a seemingly unrelated regression system
(2) Υ = [In ⊗ T]β+ µ ,
where Υ is a vector of n related health knowledge outcomes, In is a n by n identity ma-
trix, and T is a vector of assignment to treatment group indicators. We derive an average
standardized effect, β˜ = 1n ∑
N
n=1
βˆn
σˆn
where βˆn is the point estimate on the treatment indi-
cator in the nth outcome regression and σˆn is the standard deviation of the control group
for outcome n (see Kling et al., 2004; Duflo et al., 2008). The average standardized ef-
fect is positive and highly significant, confirming that overall the intervention improved
households health knowledge.
[TABLE 5 HERE]
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Health behavior and morbidity
Table 6 depicts the results on the households’ preventative health actions as well as mor-
bidity. In principle, these self-reported outcomes on the individual’s health behavior
could be difficult to interpret because of the potential recall and social desirability biases
in self-reported data (Strauss and Thomas, 1998; Powers et al, 2008). However, in this con-
text these results should be viewed as complements to the more robust health outcomes
of mortality and anthropometric data. The findings in Table 6 reveal that households in
the treatment group were 3.8 percentage points (control mean is 77.4%) more likely to
have treated their water before use and their children were 13 percent more likely to have
slept under an insecticide-treated bednet. These outcomes can be linked to the presence
of the CHP, who is incentivized to promote and sell both of the health products associated
to this preventative behavior – water purification tablets and insecticide treated bednets
– to households with young children.
Self-reported morbidity in malaria and diarrhea did not differ between control and
treatment groups. Conditional on falling sick with malaria children in the treatment
group were as likely as children in the control group to have received treatment with
ACTs for at least 3 days. However, conditional on falling sick with diarrhea children
in the treatment group were 16.2 percent more likely to have received treatment with
ORS/Zinc.
The average standardized effect reported in column (viii) indicates that overall the
intervention led to significant improvements in household health behavior.
[TABLE 6 HERE]
Health visits
One of the important tasks of the CHP was to build up a stable customer-base by provid-
ing health education, referrals, and newborn visits. Follow-up visits and revisits to sick
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households would arguably create trust between the health worker and the household.
Table 8 looks at the occurrence of follow-ups among households. Households in the treat-
ment area with a newborn baby were 71% more likely to have received a follow-up visit
in the first week after birth compared to households in the control areas. Similarly, house-
holds with a child under-five in the trial areas that fell sick with malaria or diarrhea were,
respectively, 73% and 62% and more likely to have received a follow-up visit compared
to households with sick children in the control areas. For households withnfants that fell
sick with malaria or diarrhea the increases were 7.3 and 8.1 percentage points, respec-
tively, which means an increase of more than 100% compared to households with sick
infants in the control areas. These are all cases that the CHP is particularly trained and
incentivized to focus on specifically newborn visits and children sick with malaria and
diarrhea and consequently, we also see an increase in follow-up visits for the youngest
children. The average standardized effect in column (vi) confirm that the program led to
a large and significant increase in the likelihood of follow-up visits.
When looking at counseling, we also see that a significantly higher share (about 10%,
significant at the 5 percent level) of women in the treatment group had been advised
to give birth with professional assistance, although the share that gave birth in a health
facility and the share of the currently pregnant women that had received at least some
antenatal care did not differ between control and treatment groups.
[TABLE 7 HERE]
4. Robustness
Our study has some limitations. First, the choice not to have surveillance or monitoring
systems in place in the study villages implied that we had to rely on retrospective recall
information. We used standardized data collection methods, and any potential recall
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lapses were expected to affect the treatment and control groups equally and thus lead to
an attenuation bias that would lead us to estimate a lower bound on the impact of the
CHP program on the outcome variables, including child mortality estimates.
Second, as we use the end of trial sample survey to define baseline residence and thus
the core sample for the analysis, selective out-migration by assignment groups could have
caused some confounding bias in our main estimates. In table 8 we test whether there was
selective in- and out-migration using enumeration data at baseline and endline combined
with data from the household survey.
[TABLE 8 HERE]
At baseline 50,617 households were residing in the trial cluster, 4,132 of whom were
estimated to have migrated out from the baseline cluster by the end of the trial. The aver-
age rate of out-migration per cluster was 7.1% and was not statistically different between
the treatment group and control group (p=0.991). An estimated 7,962 households moved
into the trial clusters during the study period. The average rate of in-migration per clus-
ter was 15.3% and was not statistically different between the treatment group and control
group (p=0.478). The share of sampled households that has moved into the cluster dur-
ing the trial period, out of the total number of sampled households, was not statistically
different between the treatment group and control group (p=0.614). Hence, measured in-
and out-migration into the study clusters were similar across assignment groups. More-
over, as showed in table 2, baseline household characteristics of the sampled households
that had lived in the same cluster for the whole study period were not statistically dif-
ferent between the treatment group and the control group. Overall, these results indicate
that the results are unlikely to be biased by migration patterns.
Third, the possibility of contamination is plausible because the study clusters, within
each zone, were geographically close. Analysis of behavioral data (interaction with CHP
in the control sites) also suggested that some, although low, contamination occurred, most
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likely causing us to estimate a lower bound on the impact of the CHP program on child
mortality.
Finally, another potential concern when studying this program is that charging for
preventive and curative products, even when prices are low, will disproportionately ben-
efit the less-poor households. Table A.1, however, suggests similar impact across the
household wealth distribution.
5. Cost effectiveness analysis
In the previous sections we have shown that the incentivized community health worker
program resulted in a large reduction in child mortality for all ages under five. This partic-
ular program was aimed to make the community health promoters self-sustainable, by al-
lowing them to become a micro-entrepreneur selling basic health products at prices below
the market price and at the same time earning a margin while also providing preventative
and basic health services. It is therefore important to investigate the cost-effectiveness of
the program.
Community health worker programs have typically been promoted as an effective
and relatively cheap way to deliver health services in low- and middle-income coun-
tries (Dahn et al, 2015). Remarkably, there is a dearth of information on the actual cost-
effectiveness of such programs (Bhutta et al, 2010; Vaughan et al, 2015). In many cases
estimates are computed using the Lives Saved Tool (LiST) (McPake et al, 2015). The LiST
relies on an empirical model to estimate, among other things, how a projected change
in inputs – typically the coverage rates of some health interventions – translates into a
reduction in child mortality. The model uses national demographic data to produce esti-
mates of lives saved in a national population, for given assumptions on the coverage of
the intervention and its impact. With the data at our disposal, we can compute the cost
effectiveness of the CHP program by taking into account the actual impact of the program
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observed in our study.
In estimating cost effectiveness, we take expenditure figures from the budgets pro-
vided by Living Goods, one of the two NGOs that managed the CHP program.14 Over
the study period the 46 Living Goods control clusters hosted an estimated 5,339 children
under five, 194 of which died before reaching the age of 5. By applying this mortality rate
to the 8,306 children located in the 62 Living Goods treatment clusters, we would have ex-
pected 302 deaths under-5 in this group of villages in the absence of the intervention. The
program led to a 31% reduction in child mortality in the Living Goods areas15, i.e. 93.5
averted deaths in the treatment clusters over the three year period of the RCT. This means
an average of 31.2 deaths averted per years. There were overall 95 CHPs operating in the
Living Goods treatment villages during the study period. This translates in an average
of 0.328 deaths averted per CHP per year. By 2013 Living Goods had a total of 466 com-
munity health promoters operating across Uganda, which implies a total of 153 deaths
averted within a year. The total yearly cost of running the CHP program in Uganda in
2013 was $647,841. This figure includes: all country-level expenses (57%), expenses re-
lated to branch offices and transportation (22%), expenses for marketing and promotion
(10%), and training (6%). Importantly, this figure does not include the original cost of
health-related goods bought by Living Goods ($247,904), as these were subsequently sold
to the CHPs. The profits made by Living Goods on these sales ($73,356) have been de-
ducted from the cost figure. Based on these figures, the estimated cost per averted death
under-five was $4,237.
14Although, as explained, the program was run by two different NGOs – Living Goods and BRAC – for
the cost effectiveness calculation we only rely on the detailed budget provided by Living Goods. The reason
is that Living Goods only focuses on implementing the CHP program, while BRAC has a vast portfolio of
activities, including microfinance and agriculture extension programs. Given the presence of synergies
across programs, it is difficult to isolate the portion of costs to be attributed to the CHP program. In any
case, due to such synergies, the costs born by BRAC would be significantly lower than those born by Living
Goods: a (self-reported) estimate of the net cost per capita served by the CHPs, is $2.07 for Living Goods
and $0.55 and BRAC. These lower costs would be less representative for another organization or institution
that wanted to replicate the CHP model. For all these reasons, we rely on the Living Goods budget and for
simplicity, we focus on the 2013 budget, i.e. the most recent budget to the study period.
15The estimated mortality reduction was 31% (pvalue=0.06) in the Living Goods sample and 23%
(pvalue=0.08) in the BRAC sample, although the difference is not statistically significant.
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This figure is about 35% of the cost per life saved that would be achieved by expand-
ing a range of health services known to be effective at saving lives ($12,000), as estimated
by the Guttmacher Institute based on a range of available cost-effectiveness estimates
(Perry and Zulliger, 2012). The Guttmacher Institute does not explicitly refer to com-
munity health workers, but the activity of the CHWs appears essential in achieving the
proposed expansion in service provision. Overall, however, it is difficult to put the $4,237
estimate in perspective, given the lack of estimates of CHW programs based on rigorous
evaluations. One way of looking at cost effectiveness, is to consider how much each life
saved would have contributed in economic activity over his or her lifetime. Dahn et al
(2015), for instance, estimate that on average, across SSA, a child under-5 will contributes
approximately $64,645 in economic activity over his or her lifetime.16 Based on this es-
timate, investment in the CHP program can result in an economic return of more than
15:1.
An alternative approach is to estimate the cost of the intervention in terms of life-year
gained and compare it with the estimates obtained through the LiST. According to WHO
estimates, life expectancy at age 5 in Uganda in 2013 was 59.5. The 153 deaths under
5 averted by the program would therefore translate in 9,104 life years saved each year.
Overall, this means a cost of $71.2 per life-year saved.17 This compares favorably to most
estimates based on LiST for a range of community health workers programs and that have
been found to vary from $82 per life-year gained in Kenya to $3,396 per life-year gained
in Indonesia (Borghi et al, 2005; McPake et al, 2015).
Overall, we consider the $4,237 figure to be a conservative estimate of the cost per life
saved for the CHP program. First, the evaluation took place when the program was still
relatively new. As the program expands, with more villages being reached, and more
16The estimate is based on the following assumptions: i) GDP per-capita $1,738; ii) expected GDP per-
capita growth of 2.5% per annum; iii) child will enter the workforce at age 18 and exit the workforce at age
56; iv) discount rate of 5% to calculate the net present value of the future cash-flows from projected lifetime
earnings.
17For simplicity in all these calculations we have abstracted away from discount factor issues and uncer-
tainty of point estimates.
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CHPs being recruited, cost effectiveness is expected to improve. For instance, based on
expansion (and budget) forecasts, Living Goods self-reported estimates on the cost per
capita served by its CHPs are expected to drop from $2.07 in 2014 to $1.21 in 2018.
Secondly, it should be kept in mind that cost per life saved or per life-year gained
are commonly used metrics to assess the cost effectiveness of a health intervention, but
there are many other dimensions that could be taken into account whenever considering
a community-based intervention. Some of the main advantages of the CHP program
are indeed impossible to monetize and could not be included in the cost-effectiveness
evaluation presented above. For instance, the fact that the program makes many more
households able to rely on primary health-care in their own village, rather than traveling
kilometers away to reach a health facility, is likely to bring a range of benefits to the
society: it lowers the time and transportation costs for the patient, while also reducing
the workload of the health facilities, freeing up resources that can be better used for other
more urgent cases. Moreover, the presence of financial incentives provides all CHPs and
their families with an additional source of income.
6. Conclusion
We estimate that the CHP program in Uganda reduced under-five mortality rate by 27%,
infant mortality rate by 33%, and neonatal mortality rate by 27% after 3 years. These
effects are supported by changes in health knowledge, preventive behavior, case man-
agement of malaria and diarrhea, and home visits. We also estimate the cost-effectiveness
of the program and find the estimated cost per averted death under-five during the study
period to be $4,237. To the best of our knowledge, this is the first assessment of the cost
effectiveness of a community health worker program, based on a rigorous RCT approach.
While a growing body of evidence has identified effective interventions that can be
delivered by community health workers, a key consideration for the success and sustain-
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ability of such programs is how high-quality performance by community workers can be
achieved and maintained. This study is the first impact evaluation of a community health
delivery intervention based on an incentivized approach. Unlike previous studies that
have primarily focused on the impact of specific interventions that could be delivered
effectively in a community setting, our focus is on how to ensure that community health
workers successfully implement a set of interventions proven to be effective if delivered
and the impact that may have on child health.
In the CHP program, community health workers operated as micro-entrepreneurs
earning an income on the sale of preventive and curative products. A concern with such
a scheme is that it may encourage overuse of medications and inappropriate treatment at
the expense of prevention and referrals. On the other hand, the provision of free services
like health education and follow-up visits was viewed as strategy to build up a loyal cus-
tomer base. More generally whether extrinsic incentives in some domains have positive
or negative impacts on intrinsic motivation in other domains is an empirical question.
The data does not suggest that the program only had an impact on incentivized services,
with evidence of increases in the promotion of healthy behavior and changed health be-
liefs. While there was a large increase in visits of newborns, for which the CHPs received
a small incentive payment, there were also large increases in follow-up visits of children
sick in malaria and diarrhea, for which no direct incentives were attached.
Our analysis has shown no significant impact on malaria prevalence and treatment.
However, similar treatment pattern does not necessarily imply similar quality of treat-
ment. Among other things, the CHPs sell authentic ACT drugs. In the private market
there is growing evidence that the market for antimalarial medicines is plagued by coun-
terfeit and substandard (fake) products, with recent estimates suggesting that as much
as a third of the antimalarial drugs sold contain too little or no active pharmaceutical
ingredients (Nayyar et al, 2012). Uganda is no exception: a smaller study conducted in
the same research areas one year into the program estimated that 37 percent of the retail
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outlets were selling substandard antimalarial drugs (Björkman et al, 2014). Poor quality
is not specific to ACTs but is a generic problem in the largely unregulated market for pre-
ventive and curative health products in many developing countries. The CHPs market
share for ACT drugs and ORS were 11.3% and 14.1% respectively. Under the assumption
that every third dose of ACT treatment sold in the private market is fake and that authen-
tic drugs are provided in the public sector (about 40% of the market share), children in
the treatment group are 19% less likely to be treated with a fake ACT medicine.
It is possible that the CHP program affected child mortality not only through the
provision of curative and preventative maternal, child, and newborn services, but also
through the subsidized sale of other health-related commodities and durables (e.g. hand
soap, improved cook stoves, fortified food, and water filters). The broad product mix,
with high-velocity items like soap and fortified foods, and low-velocity but high returns
per sold unit items like improved cook stoves, was deemed crucial to motivate agents
to be out visiting households regularly and for driving up total sales and income for the
CHPs.
With the accumulated know-how we have today few would question the potential
of community health care provision. How to best ensure that CHW deliver timely and
appropriate services is, however, largely an open question and motivates the contin-
ued search for innovative approaches. The CHP program we studied here harnesses
the power of franchised direct selling (business-in-a-bag) to provide community health
providers with incentives to increase access to low-cost, high-impact health products and
basic newborn and child health services. As of the end of 2016, the program was active in
over 5,500 clusters with a total population of over 4.4 million and the scale-up is continu-
ing and by end of 2018 it is estimated to reach over 5.3 million individuals in more than
6,700 clusters. The impact of the CHP program was conditional on existing facility based
professional health care as availability of referral services is a crucial component to the
program. Thus the findings should encourage government and non-government organi-
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zations to continue improving their facility based care, but also points to the importance
of integrating the program into the existing health service provision strategy. The pro-
cess of integrating the CHP program we have evaluated here into the overall health care
system is currently underway.
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FIGURES & TABLES
Figure 1: Map of Districts and Distribution of Clusters
Notes: Green fully-colored areas indicate districts that were part of the study, while cross-hatched areas
indicate districts excluded from the study, but in which the program was also implemented. Red and
blue dots indicate respectively control and intervention villages included in the study. Figure A.1 in
Appendix provides a set of more detailed images by study district.
34
Figure 2: Trial Profile
35
Table 1: Baseline Characteristics
Variables Treatment Group Control Group p-value
Number of clusters 115 99
Households per cluster 250 (113) 221 (107) 0.226
Households with under-5 children per cluster 86 (47) 78 (46) 0.665
Distance to main road 5.6 (11.6) 6.8 (12.7) 0.126
Distance to electricity transmission line 1.8 (1.5) 1.8 (1.5) 0.707
Distance to health center 1.4 (1.1) 1.7 (1.2) 0.256
Number of health centers within 5 km 8.3 (5.0) 7.3 (5.2) 0.459
Distance to hospital 10.4 (8.5) 11.1 (8.5) 0.916
Notes: Cells report mean (SD) across clusters included in the treatment or control group. A variety of sources were
consulted to generate the original dataset, including documents and maps from national utilities, regional power pools,
and the World Bank. Information on households and households with under-5 children per cluster was collected from the
enumeration of trial villages at baseline. Data for medium and high voltage electricity transmission lines was obtained
from the Africa electricity transmission network (AICD) study. Health Centers takes into account facilities from HCIII (i.e.
parish-level health centers, roughly one per 5,000 people) and above. Hospitals refer only to district/national hospitals
(roughly one per 500,000 people). Distance measures are all expressed in kilometers.
Table 2: Baseline Characteristics of Households not Lost to Follow-up and Surveyed at Endline
Variables Treatment Group Control Group p-value
A. Infant mortality
Years of exposure to risk of death under 1 year 1927 1743
Deaths under 1 year 101 87
Mortality rate per 1000 years of exposure 52.4 50.0 0.830
B. Households
Number of household 3787 3217
Household size 5.2 (2.3) 5.3 (2.3) 0.518
Age household head 36.4 (12.1) 36.7 (12.4) 0.641
Years of education household head 8.0 (0.4) 8.0 (0.2) 0.320
Notes: Cells report mean (SD) from endline sample household survey data for household that have remained in the cluster
throughout the trial, with values scaled back to baseline period.
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Table 8: Population Data and Flows
Intervention group Control group
(115 clusters) (99 clusters) p-value
Rate of in-migration 0.16 (0.12) 0.15 (0.11) 0.478
Rate of out-migration 0.07 (0.13) 0.07 (0.13) 0.991
Share of migrants 0.14 (0.09) 0.13 (0.08) 0.614
Notes: Data are mean (SD) estimated by combining data from baseline census, endline census, and end-
line sample household survey. P-values are adjusted for the stratified randomized design. Rate of in-
migration is ij/bj and rate of out-migration is oj/bj, where ij = θˆj × ej, oj = bj − (i− θˆj)× ej, bj is number
of households residing in cluster j at baseline, ej is number of households residing in cluster j at endline,
and the share of migrants θˆj is an estimate of the share of households in cluster j that moved in to the clus-
ter during the trial period, out of the total number of households living in the cluster at endline, based on
the sample household survey.
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APPENDIX
Table A.1: Under-5 mortality by wealth quartiles
Intervention group Control group
(3,790 households) (3,228 households)
Quartile I
Years of exposure to the risk of death 3,547 3,121
Reported deaths under-5 57 58
Mortality rate per 1000 years of exposure 16.1 18.6
Quartile II
Years of exposure to the risk of death 2,918 2,750
Reported deaths under-5 42 53
Mortality rate per 1000 years of exposure 14.4 19.3
Quartile III
Years of exposure to the risk of death 3,075 2,500
Reported deaths under-5 42 48
Mortality rate per 1000 years of exposure 13.7 19.2
Quartile IV
Years of exposure to the risk of death 2,724 2,321
Reported deaths under-5 41 45
Mortality rate per 1000 years of exposure 15.1 19.4
Data are n and mortality rates from endline sample household survey. Wealth has been computed combining
eight variables capturing ownership of durable assets (two sets of clothes for each household member, mobile
phone, radio and television), infrastructure and housing characteristics (electricity, roof and floor material)
and consumption habits (number of meals containing fish or meet served in a week), using Principal Com-
ponent Analysis (PCA). The wealth index increases moving from quartile I to quartile IV. For 22 households
asset information is missing.
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Figure A.1: Maps by Study District
(a) Arua District (b) Bushenyi (West)/Sheema (East) Districts
(c) Jinja District (d) Mbale District
(e) Mpigi District (f) Mukono District
(g) Pallisa District (h) Ibanda (North)/Mbarara (South) Districts
Notes: These figures are expansions of the map reported in figure 1. Green fully-colored indicate districts that were part of the
study. Red and blue dots indicate respectively control and intervention villages included in the study.44
Figure A.2: Computation of the months of exposure to the risk of death under-5 during the trial period
Notes: For each child, the number of month of exposure to the risk of death under 5 during the trial period is computed as the
number of months between the birth date of the child, or the start date of the trial (January 2011) if the child was born before that
date, and the date that the child turned five years if that occurred during the trial period, or the date of the endline household
survey if the child was less than five years old at that time, or the date of the death of the child. The figure illustrates these
different possibilities using the example of three children: child 1 was born before January 2011 and turned five at time C (the
same computation would hold if the child died under age 5 at time C). Hence the exposure to the risk of death under 5 for child 1
is represented by the (rounded) number of months between January 2011 and time C. Child 2 was instead born at time A, during
the trial period, but died at time D. Hence, in this case the exposure to the risk of death under 5 is represented by the (rounded)
number of months between time A and D. Finally, child 3 was also born during the trial, at time B, and was still alive at the time
of the endline. In this case the exposure to the risk of death under 5 is represented by the (rounded) number of months between
time B and the time of the endline survey.
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